###begin article-title 0
###xml 22 28 22 28 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP1B1</italic>
###xml 38 46 <span type="species:ncbi:9606">patients</span>
Molecular analysis of CYP1B1 in Omani patients with primary congenital glaucoma: a pilot study
###end article-title 0
###begin title 1
Purpose
###end title 1
###begin p 2
###xml 30 36 30 36 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP1B1</italic>
###xml 71 79 <span type="species:ncbi:9606">patients</span>
To screen cytochrome P4501B1 (CYP1B1) for causative mutations in Omani patients with a clinical diagnosis of primary congenital glaucoma (PCG)
###end p 2
###begin title 3
Methods
###end title 3
###begin p 4
###xml 274 280 274 280 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP1B1</italic>
###xml 52 60 <span type="species:ncbi:9606">patients</span>
###xml 157 165 <span type="species:ncbi:9606">patients</span>
###xml 341 349 <span type="species:ncbi:9606">patients</span>
Nine PCG families were recruited for the study. All patients underwent detailed clinical examinations to confirm the diagnosis of PCG. The families of index patients were also examined. Genealogical information was obtained by pedigree analysis. The primary candidate gene, CYP1B1, was amplified from genomic DNA, sequenced, and analyzed in patients to identify the disease-causing mutations.
###end p 4
###begin title 5
Results
###end title 5
###begin p 6
###xml 80 86 80 86 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP1B1</italic>
###xml 507 513 507 513 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP1B1</italic>
###xml 187 195 <span type="species:ncbi:9606">patients</span>
###xml 207 215 <span type="species:ncbi:9606">patients</span>
###xml 367 374 <span type="species:ncbi:9606">patient</span>
Eight of the nine PCG families were consanguineous (89%). Molecular analysis of CYP1B1 showed three distinct mutations, p.G61E, p.D374N, and p.R368H, in seven of nine unrelated PCG index patients (78%). Six patients had homozygous mutations and one had a compound heterozygous mutation. Causative mutations were not identified in two families. In family 4, the index patient was found to be heterozygous for the p.E229K variant. In family 6, although affected individuals were found to be homozygous in the CYP1B1 region, no mutation could be identified.
###end p 6
###begin title 7
Conclusions
###end title 7
###begin p 8
###xml 26 32 26 32 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP1B1</italic>
###xml 205 211 205 211 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP1B1</italic>
###xml 112 120 <span type="species:ncbi:9606">patients</span>
This study indicates that CYP1B1 could be the predominant cause of PCG in the Omani population (78%). Omani PCG patients show allelic heterogeneity. Further studies are needed to delineate the spectrum of CYP1B1mutations in Omani PCG families and to identify new or modifier genes contributing to the manifestations of PCG in this region.
###end p 8
###begin title 9
Introduction
###end title 9
###begin p 10
###xml 54 59 54 59 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GLC3)</italic>
###xml 454 455 454 455 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r1">1</xref>
###xml 576 577 576 577 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r1">1</xref>
Primary congenital glaucoma (PCG; OMIM ; gene symbol, GLC3) is characterized by congenital elevation of intraocular pressure (IOP) consequent to impaired aqueous outflow via the trabecular meshwork. While uncommon in the West (less than 1 in 30,000 live births), PCG is relatively common in the Middle East with an estimated incidence of 1 in 2,500 live births. This is partly attributed to the high incidence of consanguineous marriages in this region [1]. In Saudi Arabia, a neighboring state of Oman, PCG has been found to be the predominant cause for childhood blindness [1].
###end p 10
###begin p 11
###xml 310 311 310 311 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r2">2</xref>
###xml 466 467 466 467 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r3">3</xref>
###xml 568 569 568 569 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r4">4</xref>
###xml 119 127 <span type="species:ncbi:9606">patients</span>
###xml 195 203 <span type="species:ncbi:9606">patients</span>
###xml 266 274 <span type="species:ncbi:9606">patients</span>
Clinically, PCG is unassociated with other ocular or systemic diseases and is divided into three subsets, newborn PCG (patients recognized at birth or in the first month of life), infantile PCG (patients presenting in the first two years of life), and juvenile PCG (patients diagnosed after two years of age) [2]. More than 80% of the cases present within the first year of life with 25% diagnosed in the neonatal period and 60% within the first six months of life [3]. In 75% of cases, both eyes are involved, and males are affected somewhat more often than females [4].
###end p 11
###begin p 12
###xml 242 243 242 243 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r5">5</xref>
###xml 244 245 244 245 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r6">6</xref>
The disease is characterized by high IOP, buphthalmos, megalocornea, and breaks in Descemet's membrane with corneal opacification. PCG in the Middle East is more aggressive and is associated with poorer therapeutic outcomes than in the West [5,6].
###end p 12
###begin p 13
###xml 242 243 242 243 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r7">7</xref>
###xml 287 292 287 292 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GLC3A</italic>
###xml 294 295 294 295 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r8">8</xref>
###xml 296 297 296 297 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r9">9</xref>
###xml 314 319 314 319 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GLC3B</italic>
###xml 321 323 321 323 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r10">10</xref>
###xml 347 352 347 352 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GLC3C</italic>
###xml 354 356 354 356 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r11">11</xref>
###xml 439 445 439 445 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP1B1</italic>
###xml 455 460 455 460 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GLC3A</italic>
###xml 509 510 509 510 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r8">8</xref>
###xml 511 512 511 512 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r9">9</xref>
###xml 734 736 734 736 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r12">12</xref>
About 10% of all PCG cases are inherited, the mode of inheritance being largely autosomal recessive with variable penetrance. Strong inheritance (vertical transmission) is rarely observed in some families and is explained by pseudodominance [7]. Three chromosomal regions, 2p21 at locus GLC3A [8,9], 1p36 at locus GLC3B [10], and 14q24.3 at locus GLC3C [11] have been reported to be associated with PCG. The only identified gene so far is CYP1B1 at locus GLC3A, and this gene encodes for cytochrome P450 1B1 [8,9]. This enzyme is a cell membrane bound monomeric mixed-function oxygenase believed to interact with an arachidonate metabolite that is important for the normal development and function of the anterior segment of the eye [12].
###end p 13
###begin p 14
###xml 79 85 79 85 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP1B1</italic>
###xml 103 105 103 105 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r13">13</xref>
###xml 293 299 293 299 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP1B1</italic>
###xml 421 423 421 423 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r11">11</xref>
###xml 455 461 455 461 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP1B1</italic>
###xml 496 498 496 498 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r14">14</xref>
To date, more than 60 mutations associated with PCG and a few polymorphisms in CYP1B1 have been found [13], one third of them being deletions or insertions, implying an inherited instability of the gene. A total of six common single nucleotide polymorphisms (SNPs) have been identified in the CYP1B1 region, one upstream of exon 2 () and five coding SNPs ( [p. R48G],  [p.A119S],  [p.V432L],  [p.D449D], and  [p.N453S]) [11]. These SNPs are embedded in a CYP1B1 region in linkage disequilibrium [14].
###end p 14
###begin p 15
###xml 145 147 145 147 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r15">15</xref>
###xml 332 338 332 338 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP1B1</italic>
###xml 229 237 <span type="species:ncbi:9606">patients</span>
###xml 358 366 <span type="species:ncbi:9606">patients</span>
There is a high incidence of consanguinity in Oman (up to 36%), which leads to a high prevalence of autosomal recessive diseases in the country [15]. To date, the genetic basis and prevalence of various mutations among Omani PCG patients has not been studied. We report the results of a pilot study to determine the distribution of CYP1B1 mutations in Omani patients with PCG.
###end p 15
###begin title 16
Methods
###end title 16
###begin p 17
###xml 207 215 <span type="species:ncbi:9606">patients</span>
This research was performed in accordance with the Declaration of Helsinki and with the approval of the Medical Research Ethics Committee of the Sultan Qaboos University (Muscat, Oman). The families of nine patients consented to participate after being informed of the nature of the research.
###end p 17
###begin p 18
###xml 4 12 <span type="species:ncbi:9606">patients</span>
###xml 127 135 <span type="species:ncbi:9606">Patients</span>
PCG patients who were registered in the ocular genetics database of the Department of Ophthalmology, SQUH, Oman were recalled. Patients with ocular abnormalities or systemic diseases suggestive of secondary glaucoma such as aniridia, anterior segment dysgenesis, Lowe syndrome, and Sturge-Weber syndrome were excluded from the study.
###end p 18
###begin p 19
###xml 4 12 <span type="species:ncbi:9606">patients</span>
###xml 737 745 <span type="species:ncbi:9606">patients</span>
All patients were examined by at least one of the authors (A.G., S.E., S.Z., A.B.), either in the office awake or sedated, or underwent an examination under anesthesia. Ophthalmic examination included evaluation of best-corrected visual acuity (with age-appropriate tests), corneal diameter, IOP (with Tonopen XL or Perkins tonometer), corneal thickness (with ultrasound pachymeter), cup-disc ratio (with indirect ophthalmsocopy with +20D), and axial length (with ultrasound biometry). IOP values were corrected for corneal thickness based on nomograms. Slit lamp examination, gonioscopy, visual field evaluation (automated visual field Humphrey 24-2 or Goldman) and fundus photography were done when feasible. Glaucoma was diagnosed if patients demonstrated an IOP >/=22 mmHg with other signs of PCG including buphthalmos, megalocornea, corneal edema, Haab's striae, and increased cup/disc ratio.
###end p 19
###begin p 20
Genealogical information was obtained by pedigree analysis. The siblings, parents, and other family members suspected to have PCG were clinically examined along with the proband.
###end p 20
###begin p 21
###xml 73 79 73 79 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP1B1</italic>
###xml 141 143 141 143 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r16">16</xref>
###xml 955 957 936 938 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r11">11</xref>
Genomic DNA was extracted from peripheral blood. The two coding exons of CYP1B1 were amplified using four previously published primer pairs [16]. For amplification, a touchdown polymerase chain reaction (PCR) program was used with annealing temperature decreasing from 65 degreesC to 55 degreesC over nine cycles followed by 24 cycles with an annealing temperature of 55 degreesC in a 25 mul mixture (PCR conditions available on request). Sequencing reactions were performed on both strands using the BigDye Terminator Cycle Sequencing Kit v3.1 (Applied Biosystems, Foster City, CA) according to the manufacturer's instructions. The products were analyzed on an ABI Genetic Analyzer 3730 (Applied Biosystems). Using segregation analysis in the families, haplotypes were constructed using the six previously mentioned common SNPs in the gene, one upstream of exon 2 () and five coding SNPs ( [p. R48G],  [p.A119S],  [p.V432L],  [p.D449D], and  [p.N453S]) [11]. Mutations when found were confirmed in family members.
###end p 21
###begin title 22
Results
###end title 22
###begin p 23
###xml 476 483 476 483 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t1">Table 1</xref>
###xml 488 495 488 495 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t2">Table 2</xref>
###xml 5 13 <span type="species:ncbi:9606">patients</span>
###xml 104 112 <span type="species:ncbi:9606">patients</span>
###xml 243 251 <span type="species:ncbi:9606">patients</span>
Nine patients with PCG (5 males, 4 females) and their families were enrolled in the study. All affected patients had IOPs greater than or equal to 21 mmHg as well as increased corneal diameters (>12mm), cup-disc ratios, and axial lengths. All patients included in the present study had an aggressive form of glaucoma with onset within the first month of life and had undergone multiple surgical interventions for control of their glaucoma. The clinical data are summarized in Table 1 and Table 2.
###end p 23
###begin title 24
###xml 26 34 <span type="species:ncbi:9606">patients</span>
Clinical details in study patients with primary congenital glaucoma I.
###end title 24
###begin p 25
All data refer to time of last examination except where stated differently. ALT - argon laser trabeculoplasty, d: day(s), Curr.: current, Dx: diagnosis, cIOP: pachymetry corrected intraocular pressure, H: horizontal, HM: hand movements, IOP: intraocular pressure, LP: light perception, m: month(s), MMC: mitomicin C, NLP: no light perception, w: week(s), NA: not applicable, ND: no data available, OD: right eye, OS: left eye, OU: both eyes, PAS: peripheral anterior synechia, Rx: Treatment, Sx: surgery, Trab - Trabeculectomy, Trab+trab: Trabeculectomy + Trabeculotomy, V-vertical, y: year(s).
###end p 25
###begin title 26
###xml 26 34 <span type="species:ncbi:9606">patients</span>
Clinical details in study patients with primary congenital glaucoma II.
###end title 26
###begin p 27
###xml 113 121 <span type="species:ncbi:9606">patients</span>
All data refer to time of last examination except where stated differently. The asterisk denotes that in two PCG patients, the age of onset was unclear (but definitely within one year of age). PCG-primary congenital glaucoma.
###end p 27
###begin p 28
###xml 91 98 91 98 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t3">Table 3</xref>
###xml 285 291 285 291 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP1B1</italic>
###xml 389 396 389 396 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t3">Table 3</xref>
###xml 506 507 506 507 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r1">1</xref>
###xml 508 510 508 510 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r17">17</xref>
###xml 612 619 612 619 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t3">Table 3</xref>
###xml 797 799 797 799 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r18">18</xref>
###xml 900 906 900 906 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP1B1</italic>
###xml 951 960 951 960 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f1">Figure 1A</xref>
###xml 1098 1104 1098 1104 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP1B1</italic>
###xml 1139 1146 1139 1146 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t3">Table 3</xref>
###xml 1203 1209 1203 1209 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP1B1</italic>
###xml 1217 1222 1217 1222 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GLC3A</italic>
###xml 1224 1233 1224 1233 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f1">Figure 1B</xref>
###xml 561 569 <span type="species:ncbi:9606">patients</span>
###xml 603 610 <span type="species:ncbi:9606">patient</span>
###xml 1041 1048 <span type="species:ncbi:9606">patient</span>
###xml 1050 1054 <span type="species:ncbi:9606">II.1</span>
###xml 1469 1477 <span type="species:ncbi:9606">patients</span>
Consanguinity was found in eight of the nine families (89%) without any gender preference (Table 3). In five families, more than one individual was affected. The presumed mode of inheritance according to pedigree analysis was autosomal recessive in all families. Molecular analysis of CYP1B1 permitted the identification of three causative mutations in seven of the nine index cases (78%; Table 3). The p.G61E, p.D374N, and p.R368H mutations have all been previously reported as disease-causing mutations [1,17]. The identified mutations were homozygous in six patients and compound heterozygous in one patient (Table 3). The mutations segregated with the disease in the seven families. The index case in family 4 presented the previously reported risk-associated but not clearly disease-causing [18] p.E229K variant in heterozygous form. Haplotype analysis for family 4 using the six coding SNPs in CYP1B1 ruled out this variant as the cause of PCG (Figure 1A). It did not segregate with the disease since the affected brother of the index patient (II.1) did not carry the variant. No mutation in CYP1B1 could be identified for family 6 (Table 3). Haplotype analysis, however, suggested linkage to the CYP1B1 locus, GLC3A (Figure 1B). Both affected individuals (II.2 and II.3) were homozygous for the same SNP haplotype, 5'-CCGGTA-3', while their unaffected sister was heterozygous. Thus, a total of 14 mutations and one risk-associated variant were found in the nine patients representing an overall mutation rate of 14 in 18 (78%) studied chromosomes.
###end p 28
###begin title 29
###xml 0 6 0 6 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP1B1</italic>
###xml 70 78 <span type="species:ncbi:9606">patients</span>
CYP1B1 mutations associated with primary congenital glaucoma in Omani patients.
###end title 29
###begin p 30
###xml 140 146 140 146 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP1B1</italic>
Consanguinity was found in eight of the nine families (89%). In five families, more than one individual was affected. Molecular analysis of CYP1B1 permitted the identification of three causative mutations in seven of the nine index cases (78%).
###end p 30
###begin p 31
###xml 62 63 62 63 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 587 588 587 588 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 670 676 670 676 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP1B1</italic>
###xml 736 742 736 742 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP1B1</italic>
###xml 162 169 <span type="species:ncbi:9606">patient</span>
###xml 171 175 <span type="species:ncbi:9606">II.2</span>
###xml 315 322 <span type="species:ncbi:9606">patient</span>
###xml 334 338 <span type="species:ncbi:9606">II.1</span>
###xml 827 831 <span type="species:ncbi:9606">II.2</span>
###xml 887 891 <span type="species:ncbi:9606">II.1</span>
Pedigree with haplotypes of family 4 (heterozygous mutation). A: Pedigree with haplotypes of family 4 (heterozygous mutation) is shown. In this family, the index patient (II.2) is heterozygous for the E229K mutation as is her unaffected dizygotic twin (II.3) and parents (I.1 and I.2). On the other hand, the index patient's brother (II.1) does not carry the E229K mutation but has the disease. This suggests that the E229K mutation cannot be causative for PCG in this family. The order of the SNPs from top to bottom is ,  (p. R48G),  (p.A119S),  (p.V432L),  (p.D449D), and  (p.N453S). B: Pedigree with haplotypes of Family 6 (no mutation) is shown. In this family, no CYP1B1 mutation was identified. Analysis of the six known SNPs in CYP1B1 revealed homozygosity for the 5'-CCGGTA-3' haplotype in both PCG-affected brothers (II.2 and II.3) and heterozygosity in the unaffected sister (II.1) and parents (I.2 and I.3). This indicates a critical role for the 5'-CCGGTA-3' haplotype in PCG. The order of the SNPs from top to bottom is: ,  (p. R48G),  (p.A119S),  (p.V432L),  (p.D449D), and  (p.N453S).
###end p 31
###begin title 32
Discussion
###end title 32
###begin p 33
###xml 171 176 171 176 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GLC3A</italic>
###xml 235 236 235 236 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r9">9</xref>
###xml 298 304 298 304 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP1B1</italic>
###xml 379 380 379 380 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r1">1</xref>
###xml 381 383 381 383 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r17">17</xref>
###xml 411 413 411 413 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r19">19</xref>
###xml 436 438 436 438 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r20">20</xref>
###xml 484 490 484 490 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP1B1</italic>
###xml 574 580 574 580 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP1B1</italic>
###xml 120 128 <span type="species:ncbi:9606">patients</span>
###xml 245 253 <span type="species:ncbi:9606">patients</span>
###xml 282 290 <span type="species:ncbi:9606">patients</span>
###xml 532 540 <span type="species:ncbi:9606">patients</span>
###xml 624 632 <span type="species:ncbi:9606">patients</span>
PCG is a genetically heterogeneous disorder that maps to at least three different loci. However, in the majority of PCG patients, the candidate locus has been found to be GLC3A, which codes for a cytochrome p450 protein called CYP1B1 [9]. Among patients with PCG, the proportion of patients due to CYP1B1 mutations is variable across populations from ~100% among Saudi Arabians [1,17] and Slovakgypsies (Roms) [19] to ~20% in Japanese [20]. We detected three distinct disease-causing CYP1B1 mutations in seven of the nine PCG index patients (78%). Our results indicate that CYP1B1 mutations play a crucial role in Omani PCG patients as in other Arab populations.
###end p 33
###begin p 34
###xml 60 66 60 66 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP1B1</italic>
###xml 156 158 156 158 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r21">21</xref>
###xml 325 327 325 327 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r17">17</xref>
###xml 328 330 328 330 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r19">19</xref>
###xml 685 686 685 686 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r1">1</xref>
###xml 687 689 687 689 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r17">17</xref>
###xml 1142 1144 1142 1144 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r22">22</xref>
###xml 70 78 <span type="species:ncbi:9606">patients</span>
###xml 213 221 <span type="species:ncbi:9606">patients</span>
###xml 428 436 <span type="species:ncbi:9606">patients</span>
###xml 503 511 <span type="species:ncbi:9606">patients</span>
###xml 725 730 <span type="species:ncbi:9606">human</span>
The worldwide profile of variations in the coding region of CYP1B1 in patients with PCG thus far reported is heterogeneous and includes ~70 alterations () [21]. However, the Slovakgypsies (Roms) and Saudi Arabian patients with PCG exhibit allelic homogeneity that has largely been attributed to consanguinity and inbreeding [17,19]. The detection of three disease-causing mutations in seven index cases indicates that Omani PCG patients show allelic heterogeneity. The three mutations we found in Omani patients (p.R368H, p.D374N, and p.G61E) have been reported as the most common mutations in the Saudi population, accounting for 72%, 12%, and 7% of the tested alleles, respectively [1,17]. Oman has been a major gateway in human history with evidence of clear contacts with sub-Saharan West Africa, East Africa (Zanzibar/Mombasa), Iraq, Iran, Pakistan, and India and is expected to have a rich genetic legacy. The degree of heterogeneity within different populations as well as the distribution of mutations have been seen to be very variable and are believed to be attributable to variations in gene pools among the different populations [22].
###end p 34
###begin p 35
###xml 33 39 33 39 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP1B1</italic>
###xml 199 205 199 205 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP1B1</italic>
###xml 146 154 <span type="species:ncbi:9606">patients</span>
Among the seven index cases with CYP1B1 mutations, one carried two different mutations (compound heterozygous). The large proportion of Omani PCG patients (6/7; 86%) carrying homozygous mutations in CYP1B1 is indicative of extensive consanguineous marriages in the Omani population.
###end p 35
###begin p 36
###xml 74 81 74 81 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t3">Table 3</xref>
###xml 83 92 83 92 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f1">Figure 1A</xref>
###xml 165 170 165 170 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GLC3A</italic>
###xml 230 237 230 237 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t3">Table 3</xref>
###xml 239 248 239 248 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f1">Figure 1B</xref>
###xml 341 347 341 347 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP1B1</italic>
The p.E229K variant found in family 4 did not segregate with the disease (Table 3, Figure 1A). Haplotype analysis suggested that mutations in a locus different than GLC3A could be responsible for PCG in this family. In family 6, (Table 3, Figure 1B) no mutation could be identified. However, both affected individuals were homozygous in the CYP1B1 region, making it likely that a mutation in the promoter or in some other regulatory region of the gene is responsible for the disease. Further work with family 4 (performing a linkage analysis after recruiting additional affected and healthy family members) and family 6 (analysis of cDNA in the affected family members) is in progress.
###end p 36
###begin p 37
###xml 168 174 168 174 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP1B1</italic>
###xml 438 444 438 444 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP1B1</italic>
###xml 373 381 <span type="species:ncbi:9606">patients</span>
Our study is the first report of molecular genetic analysis of PCG in the Omani population. To verify the results of this pilot study, to further delineate the role of CYP1B1 mutations in the pathogenesis of PCG in the Omani population, and to identify new or modifier genes contributing to the manifestations of PCG in this region, further studies with a larger sample of patients are being planned. Identifying the mutation spectrum of CYP1B1 that causes PCG in the Omani population has implications in devising molecular diagnostics for rapid screening in predisposed families that would aid in early intervention.
###end p 37
###begin title 38
Acknowledgments
###end title 38
###begin p 39
###xml 231 236 <span type="species:ncbi:9606">Human</span>
###xml 347 355 <span type="species:ncbi:9606">patients</span>
This study was supported by grants from the MREC (Sultan Qaboos University, Oman; MREC 229) and the Deutsche Forschungsgemeinschaft, Sonderforschungsbereich Glaukome (SFB 539). We are grateful to Professor Andre Reis (Institute of Human Genetics, Friedrich Alexander University, Erlangen, Germany) for the molecular genetic analyses. We thank the patients and their families for their participation in the study.
###end p 39
###begin title 40
References
###end title 40
###begin article-title 41
###xml 0 6 0 6 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP1B1</italic>
###xml 124 131 124 131 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">de novo</italic>
CYP1B1 mutations and incomplete penetrance in an inbred population segregating primary congenital glaucoma suggest frequent de novo events and a dominant modifier locus.
###end article-title 41
###begin article-title 42
Primary congenital glaucoma: 2004 update.
###end article-title 42
###begin article-title 43
Primary infantile glaucoma (congenital glaucoma).
###end article-title 43
###begin article-title 44
Trabeculectomy with Mitomycin-C versus trabeculectomy with 5-Fluorouracil for the treatment of childhood glaucoma.
###end article-title 44
###begin article-title 45
Combined trabeculotomy and trabeculectomy as an initial procedure in uncomplicated Congenital glaucoma.
###end article-title 45
###begin article-title 46
Assignment of a locus (GLC3A) for primary congenital glaucoma (Buphthalmos) to 2p21 and evidence for genetic heterogeneity.
###end article-title 46
###begin article-title 47
Identification of three different truncating mutations in cytochrome P4501B1 (CYP1B1) as the principal cause of primary congenital glaucoma (Buphthalmos) in families linked to the GLC3A locus on chromosome 2p21.
###end article-title 47
###begin article-title 48
A second locus (GLC3B) for primary congenital glaucoma (buphthalmos) maps to the 1p36 region.
###end article-title 48
###begin article-title 49
Molecular genetics of primary congenital glaucoma in Brazil.
###end article-title 49
###begin article-title 50
12(R)-hydroxyicosatetraenoic acid: a cytochrome P450-dependent arachidonate metabolite that inhibits Na+,K+-ATPase in the cornea.
###end article-title 50
###begin article-title 51
Role of CYP1B1 in glaucoma.
###end article-title 51
###begin article-title 52
Primary congenital glaucoma and Rieger's anomaly: extended haplotypes reveal founder effects for eight distinct CYP1B1 mutations.
###end article-title 52
###begin article-title 53
A study of consanguinity in the Sultanate of Oman.
###end article-title 53
###begin article-title 54
Novel CYP1B1 and known PAX6 mutations in anterior segment dysgenesis (ASD).
###end article-title 54
###begin article-title 55
###xml 13 19 13 19 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP1B1</italic>
Mutations in CYP1B1, the gene for cytochrome P4501B1, are the predominant cause of primary congenital glaucoma in Saudi Arabia.
###end article-title 55
###begin article-title 56
Mutations in CYP1B1 cause primary congenital glaucoma by reduction of either activity or abundance of the enzyme.
###end article-title 56
###begin article-title 57
###xml 37 43 37 43 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP1B1</italic>
Identification of a single ancestral CYP1B1 mutation in Slovakgypsies (Roms) affected with primary congenital glaucoma.
###end article-title 57
###begin article-title 58
###xml 26 32 26 32 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP1B1</italic>
###xml 61 69 <span type="species:ncbi:9606">patients</span>
Novel cytochrome P4501B1 (CYP1B1) gene mutations in Japanese patients with primary congenital glaucoma.
###end article-title 58
###begin article-title 59
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human Gene Mutation Database (HGMD): 2003 update.
###end article-title 59
###begin article-title 60
Globally, CYP1B1 mutations in primary congenital glaucoma are strongly structured by geographic and haplotype backgrounds.
###end article-title 60

